6 news items
Aurinia Announces 2024 Annual General Meeting Results
AUPH
14 Jun 24
, J.D., K.C., Director, Chair of the Governance & Nomination Committee and Member of the Compensation Committee; and Brinda Balakrishnan, M.D., Ph.D
Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce
AUPH
4 Jun 24
with Mr. Selce's idea would be completely at odds with sound corporate governance practices and, if followed by shareholders, could result in a public
Aurinia Pharmaceuticals Shareholder Urges Fellow Shareholders to Withhold Support for CEO Peter Greenleaf
AUPH
3 Jun 24
.
Given this level of value destruction and the governance and strategic issues
Aurinia Pharmaceuticals Shareholder Urges Board Of Directors To Take Action To Enhance Shareholder Value; Outlines Concerns Regarding The Company's Current Strategy And Board Composition And Offers Superior Paths To Improving Performance And Market Penetration
AUPH
7 May 24
the solutions we have proposed to improve Aurinia's performance, governance and go-forward strategy. Further, ILJIN – as a preeminent shareholder owning
Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value
AUPH
7 May 24
to improve Aurinia's performance, governance and go-forward strategy. Further, ILJIN – as a preeminent shareholder owning more than 5% of the Company's
czqr1exhmthcdple 0liq3efj
AUPH
2 May 24
released its 2023 ESG report, which details the holistic approach the Company takes to address environmental, social and governance priorities, including
- Prev
- 1
- Next